Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 82

Results For "public"

1048 News Found

Jeffrey W. Fisher is the recipient of the Arnold J Lehman SOT award
News | March 16, 2022

Jeffrey W. Fisher is the recipient of the Arnold J Lehman SOT award

Career achievement for contributions in Physiologically based pharmacokinetic (PBPK) and biologically based does response (BBDR) modelling tools


Oppilotech and Evariste technologies partner for anti-bacterial programme
Biotech | March 16, 2022

Oppilotech and Evariste technologies partner for anti-bacterial programme

Machine learning approach to systems biology combined with ligand discovery platform


Single-cell DNA sequencing identifies genetic mechanism in brain lesion formation
Biotech | March 15, 2022

Single-cell DNA sequencing identifies genetic mechanism in brain lesion formation

Tapestri Platform powers Nature Cardiovascular Research publication that identifies two somatic mutations associated with sporadic brain blood vessel disorder


Krsnaa Diagnostics appoints Dr Ravinder Sethi as Chief Operating Officer
People | March 14, 2022

Krsnaa Diagnostics appoints Dr Ravinder Sethi as Chief Operating Officer

He was earlier associated with leading industry players like Hindustan Unilever, TATA Communications, Dr. Lal Path Labs, Oncquest and Metropolis Healthcare


Applications for PLI in bulk drugs extended till March 31st 2022
News | March 14, 2022

Applications for PLI in bulk drugs extended till March 31st 2022

A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore


BioPharma’s Herceptin biosimilar Phase 3 results positive
Biotech | March 12, 2022

BioPharma’s Herceptin biosimilar Phase 3 results positive

The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile


Moderna begins Phase 2 study of Omicron-specific bivalent booster
Biotech | March 11, 2022

Moderna begins Phase 2 study of Omicron-specific bivalent booster

Moderna's Omicron-specific bivalent booster candidate combines its Omicron-specific booster candidate with its Covid-19 vaccine


Emmes acquires Casimir, its fourth major acquisition
Biotech | March 11, 2022

Emmes acquires Casimir, its fourth major acquisition

Casimir further differentiates Emmes’ industry-leading rare disease research capabilities


AXA in India boosts telemedicine helpline with free specialist teleconsultation feature
Digitisation | March 10, 2022

AXA in India boosts telemedicine helpline with free specialist teleconsultation feature

SAATH is a ‘One AXA’ public health initiative between AXA France Vie, AXA GO Business Operations, and AXA XL


Metropolis Healthcare announces 2nd edition of Healthcare Heroes awards
Clinical Trials | March 10, 2022

Metropolis Healthcare announces 2nd edition of Healthcare Heroes awards

As a part of its CSR initiatives, the ‘Healthcare Heroes of India’ Awards by Metropolis aims to identify and recognize those individuals and institutions in healthcare sector with a strong sense of purpose and commitment towards patient care and who have prioritized it over all other growth parameters